Department of Experimental Pharmacology and Toxicology, School of Pharmacy, 12510Jilin University, Changchun, China.
Department of Pathology, 154516The Third Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Hum Exp Toxicol. 2021 Dec;40(12_suppl):S553-S562. doi: 10.1177/09603271211033774. Epub 2021 Nov 17.
Idarubicin (IDA) is an anthracycline antibiotic, frequently used for the treatment of various human cancers. rodent model studies have identified a variety of possible adverse outcomes from IDA including heart effects like increased heart weights, myocardial histopathological injury, electrocardiogram abnormalities, and cardiac dysfunction. Despite significant investigations, the molecular mechanisms responsible for the cardiotoxicity of IDA have not been fully clarified. The aim of the current study was to investigate the effects of IDA on the HL-1 cardiac muscle cell. Different concentrations of IDA (10, 10, 10, and 10 M) were used at different time (6, 12, 24, and 48 h) periods, and the Cell Counting Kit-8 (CCK-8); 2,7-dichlorodihydrofluorescein diacetate (DCFH-DA) probe method; and enzyme-linked immunosorbent assay (ELISA) were used to detect the oxidative stress level. In addition, we used network analysis to predict IDA-induced cardiotoxicity. The TUNEL assay, qRT-PCR, ELISA assay, and Western blotting detection of related apoptotic factors including caspase family, Bax, and Bcl-2. Overall, we found that IDA was generally more toxic at high concentrations or extended durations of exposure. At the same time, IDA can increase the content of reactive oxygen species (ROS), malondialdehyde (MDA), and decrease the level of superoxide dismutase (SOD), catalase (CAT), and glutathione (GSH) in cells, and increase the content of lactate dehydrogenase (LDH) and nitric oxide synthase (NOS) in the medium. Network analysis showed that the apoptosis signaling pathway was activated; specifically, the caspase family was involved in the signal pathway. The results of the TUNEL assay, qRT-PCR, ELISA, and Western blot found that IDA can activate apoptotic factors. The mechanism may be related to the activation of apoptosis signaling pathway. These results indicate that the cardiotoxic effects of IDA are most likely associated with oxidative stress and ROS formation, which finally ends in apoptotic factors' activation and induction of cell apoptosis.
伊达比星(IDA)是一种蒽环类抗生素,常用于治疗各种人类癌症。啮齿动物模型研究已经确定了 IDA 可能产生的多种不良后果,包括心脏效应,如增加心脏重量、心肌组织病理学损伤、心电图异常和心功能障碍。尽管进行了大量研究,但 IDA 致心脏毒性的分子机制尚未完全阐明。本研究旨在探讨 IDA 对 HL-1 心肌细胞的影响。不同浓度(10、10、10 和 10 M)的 IDA 在不同时间(6、12、24 和 48 h)作用,使用细胞计数试剂盒-8(CCK-8);2,7-二氯二氢荧光素二乙酸酯(DCFH-DA)探针法;和酶联免疫吸附测定(ELISA)检测氧化应激水平。此外,我们使用网络分析来预测 IDA 诱导的心脏毒性。TUNEL 检测、qRT-PCR、ELISA 检测和相关凋亡因子(包括半胱氨酸天冬氨酸蛋白酶家族、Bax 和 Bcl-2)的 Western 印迹检测。总的来说,我们发现 IDA 通常在高浓度或延长暴露时间时毒性更大。同时,IDA 可增加细胞内活性氧(ROS)、丙二醛(MDA)的含量,降低细胞中超氧化物歧化酶(SOD)、过氧化氢酶(CAT)和谷胱甘肽(GSH)的水平,并增加细胞内乳酸脱氢酶(LDH)和一氧化氮合酶(NOS)的含量。网络分析表明,凋亡信号通路被激活;具体来说,半胱氨酸天冬氨酸蛋白酶家族参与了信号通路。TUNEL 检测、qRT-PCR、ELISA 和 Western blot 的结果发现,IDA 可以激活凋亡因子。其机制可能与凋亡信号通路的激活有关。这些结果表明,IDA 的心脏毒性作用很可能与氧化应激和 ROS 形成有关,最终导致凋亡因子的激活和细胞凋亡的诱导。